Register
Cart (0)

Home > Products > Assay Kits > Human PlGF Kit

Contact an Account Manager

Human PlGF Kit

Click image to enlarge

The Human PlGF Kit provides assay-specific components for the quantitative determination of endogenous placental growth factor (PlGF) in human serum, plasma, and tissue culture supernatant.

Specifications
Kit Contents
Documentation
References

Application(s)		Cardiovascular
Analyte(s)		PlGF
Species		Human
Plate Type		96-well
Instrument(s)		MESO SECTOR S 600MM , MESO QuickPlex SQ 120MM , MESO SECTOR S 600 , MESO QuickPlex SQ 120 , SECTOR Imager 6000 , SECTOR Imager 2400
Capture Antibody		Mouse Monoclonal
Detection Antibody		Goat Polyclonal
LLOD (Sensitivity)		1 pg/mL
Dynamic Range		1-9000 pg/mL
Recombinant standards		Recombinant human PlGF
Usage Statement		For Research Use Only. Not for use in diagnostic procedures.
Storage Statement(s)		Please refer to the product insert for the storage conditions of individual kit components.
Storage Condition		Multi-Component

Kit Contents for Catalog No. K151BNC-1

Product Description	Storage	Quantity per Kit
Human PlGF Calibrator	≤-70 °C	1 vial (30 μL)

SULFO-TAG Anti-human PlGF Antibody	2-8 °C	1 vial (40 μL)

Human PlGF Plate	2-8 °C	1 each (1 each)

Diluent 8	≤-10 °C	1 each (5 mL)

Diluent 7	≤-10 °C	1 each (5 mL)

Diluent 9	≤-10 °C	1 each (10 mL)

Read Buffer T 4X	RT	1 each (50 mL)

Blocker C, 100 mL	2-8 °C	1 each (100 mL)

Kit Contents for Catalog No. K151BNC-2

Product Description	Storage	Quantity per Kit
Human PlGF Calibrator	≤-70 °C	5 vial (30 μL)

SULFO-TAG Anti-human PlGF Antibody	2-8 °C	1 vial (200 μL)

Human PlGF Plate	2-8 °C	5 each (1 each)

Diluent 8	≤-10 °C	1 each (50 mL)

Diluent 7	≤-10 °C	1 each (50 mL)

Diluent 9	≤-10 °C	2 each (50 mL)

Read Buffer T 4X	RT	1 each (50 mL)

Blocker C, 100 mL	2-8 °C	1 each (100 mL)

Kit Contents for Catalog No. K151BNC-3

Product Description	Storage	Quantity per Kit
Human PlGF Calibrator	≤-70 °C	20 vial (30 μL)

SULFO-TAG Anti-human PlGF Antibody	2-8 °C	4 vial (200 μL)

Human PlGF Plate	2-8 °C	20 each (1 each)

Diluent 8	≤-10 °C	2 each (50 mL)

Diluent 7	≤-10 °C	2 each (50 mL)

Diluent 9	≤-10 °C	4 each (50 mL)

Read Buffer T 4X	RT	1 each (200 mL)

Blocker C, 1 LT	2-8 °C	1 each (1000 mL)

Order Details

K151BNC

Select your instrument:

S 600

SQ 120

Q 60

Catalog No

Size

Status

K151BNC-1

1 plate

K151BNC-2

5 plates

K151BNC-3

20 plates

Contact Information

Customer Service/Orders
1-240-314-2795

5:00 a.m. to 8:00 p.m.
US Eastern Time

Email

Scientific/Technical Support
1-240-314-2798

8:30 a.m. to 5:30 p.m.
US Eastern Time

Email

Instrument Support
1-301-947-2057

8:30 a.m. - 5:30 p.m.
US Eastern Time

Email

Company Headquarters
1-240-314-2600
1601 Research Blvd.
Rockville, Maryland 20850-3173
USA

Product Inserts		Human PlGF Serum
SDS		Diluent 2, Diluent 3, Diluent 5, Diluent 7 and Diluent 8 MSD Calibrators and Controls Read Buffer T (4x), Read Buffer S (4x) and Read Buffer S (1x)

Title	Journal	Year
A phase II and biomarker study of ramucirumab, a human monoclonal antibody targeting the VEGF receptor-2 in patients with advanced hepatocellular cancer. Zhu AX, Finn RS, Mulcahy M, Gurtler J, Sun W, Schwartz JD, Dalal RP, Joshi A, Hozak RR, Xu Y, Ancukiewicz M, Jain RK, Nugent F, Duda DG, Stuart K.	Clin Cancer Res.	2013
Phase I study of Dovitinib (TKI258), an oral FGFR, VEGFR, and PDGFR inhibitor, in advanced or metastatic renal cell carcinoma. Angevin E, Lopez-Martin JA, Lin CC, Gschwend JE, Harzstark A, Castellano D, Soria JC, Sen P, Chang J, Shi M, Kay A, Escudier B.	Clin Cancer Res	2013
Effects of Sorafenib on Intra-Tumoral Interstitial Fluid Pressure and Circulating Biomarkers in Patients with Refractory Sarcomas (NCI Protocol 6948). Raut CP, Boucher Y, Duda DG, Morgan JA, Quek R, Ancukiewicz M, Lahdenranta J, Eder JP, Demetri GD, Jain RK.	PLoS One.	2012
Pharmacokinetic and pharmacodynamic analysis of circulating biomarkers of anti-NRP1, a novel anti-angiogenesis agent, in two phase I trials in patients with advanced solid tumors. Xin Y, Li J, Wu J, Kinard R, Weekes CD, Patnaik A, Lorusso PM, Brachmann R, Tong RK, Yan Y, Watts R, Bai S, Hegde PS.	Clin Cancer Res.	2012
Phase 1b dose-finding study of motesanib with docetaxel or paclitaxel in patients with metastatic breast cancer. De Boer RH, Kotasek D, White S, Koczwara B, Mainwaring P, Chan A, Melara R, Ye Y, Adewoye AH, Sikorski R, Kaufman PA.	Breast Cancer Res Treat.	2012
View All

Please Sign In

User name

Password

Human PlGF Kit

Kit Contents for Catalog No. K151BNC-1

Kit Contents for Catalog No. K151BNC-2

Kit Contents for Catalog No. K151BNC-3

Order Details

K151BNC

S 600

SQ 120

Q 60

Top Products

Contact Information

Products

Services

Orders & Support

Key Topics